Yiqun Jiang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Dna Damage Response

Epidermal Growth Factor Receptor

Top Venues

Cell death & disease

Journal of immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Hua He, Lu Liang, Shiyao Jiang, Yueying Liu, Jingjing Huang, Xiaoyan Sun, Yi Li, Yiqun Jiang, Li Cong
GINS2 regulates temozolomide chemosensitivity via the EGR1/ECT2 axis in gliomas. Cell death & disease 15 (3) (2024)
Hua He, Lu Liang, Shiyao Jiang, Yueying Liu, Jingjing Huang, Xiaoyan Sun, Yi Li, Yiqun Jiang, Li Cong
GINS2 regulates temozolomide chemosensitivity via the EGR1/ECT2 axis in gliomas. Cell death & disease 15 (3) (2024)
Hua He, Lu Liang, Shiyao Jiang, Yueying Liu, Jingjing Huang, Xiaoyan Sun, Yi Li, Yiqun Jiang, Li Cong
GINS2 regulates temozolomide chemosensitivity via the EGR1/ECT2 axis in gliomas. Cell death & disease 15 (3) (2024)
Jing Liu, Lijuan Wang, Hua He, Yueying Liu, Yiqun Jiang, Jinfeng Yang
The Complex Role of Chaperone-Mediated Autophagy in Cancer Diseases. Biomedicines 11 (7) (2023)
Lu Liang, Yueying Liu, Shiyao Jiang, Jingjing Huang, Hua He, Li Shen, Li Cong, Yiqun Jiang
Novel Circulating Tumour Cell-Related Risk Model Indicates Prognosis and Immune Infiltration in Lung Adenocarcinoma. Journal of immunology research 2022 (2022)
Shiyao Jiang, Jingjing Huang, Hua He, Yueying Liu, Lu Liang, Xiaoyan Sun, Yi Li, Li Cong, Bei Qing, Yiqun Jiang
NCAPG2 Maintains Cancer Stemness and Promotes Erlotinib Resistance in Lung Adenocarcinoma. Cancers 14 (18) (2022)
Lu Liang, Hua He, Shiyao Jiang, Yueying Liu, Jingjing Huang, Xiaoyan Sun, Yi Li, Yiqun Jiang, Li Cong
TIAM2 Contributes to Osimertinib Resistance, Cell Motility, and Tumor-Associated Macrophage M2-like Polarization in Lung Adenocarcinoma. International journal of molecular sciences 23 (18) (2022)
Hua He, Jingjing Huang, Sufang Wu, Shiyao Jiang, Lu Liang, Yueying Liu, Wenbing Liu, Li Xie, Yongguang Tao, Yiqun Jiang, Li Cong
The roles of GTPase-activating proteins in regulated cell death and tumor immunity. Journal of hematology & oncology 14 (1) (2021)